Kobayashi, Y., Inagawa, H., Kohchi, C., Kazumura, K., Tsuchiya, H., Miwa, T., . . . Soma, G. (2018). Oral administration of Pantoea agglomerans-derived lipopolysaccharide prevents development of atherosclerosis in high-fat diet-fed apoE-deficient mice via ameliorating hyperlipidemia, pro-inflammatory mediators and oxidative responses. PLoS One.

Kobayashi, Yutaro, Hiroyuki Inagawa, Chie Kohchi, Kimiko Kazumura, Hiroshi Tsuchiya, Toshiyuki Miwa, Katsuichiro Okazaki, and Gen-Ichiro Soma. "Oral Administration of Pantoea Agglomerans-derived Lipopolysaccharide Prevents Development of Atherosclerosis in High-fat Diet-fed ApoE-deficient Mice Via Ameliorating Hyperlipidemia, Pro-inflammatory Mediators and Oxidative Responses." PLoS One 2018.

Kobayashi, Yutaro, et al. "Oral Administration of Pantoea Agglomerans-derived Lipopolysaccharide Prevents Development of Atherosclerosis in High-fat Diet-fed ApoE-deficient Mice Via Ameliorating Hyperlipidemia, Pro-inflammatory Mediators and Oxidative Responses." PLoS One 2018.